Please assess the completion status of the following clinical trial:

Trial Title: Magnetic Brain Stimulation for the Treatment of Adult Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of major depression with a current episode~* Hamilton Rating Scale for Depression score higher than 20~* No response or intolerance to antidepressant medication in the current depressive episode~Exclusion Criteria:~* Current use of antidepressants~* Diagnosis of psychosis or anxiety disorder~* Current substance abuse~* Seizures or history of head trauma

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Active prefrontal rTMS phase1 (Type: EXPERIMENTAL): Phase I participants receiving rTMS
- Sham rTMS phase 1 (Type: PLACEBO_COMPARATOR): Phase I participants receiving sham stimulation
- rTMS extension (Type: EXPERIMENTAL): rTMS. Phase II participants, all of whom did not meet remission requirements after phase 1. They all receive active open label rTMS
- Open label antidepressant regimen (Type: EXPERIMENTAL): All patients who met remission who were then transitioned to medications after the TMS trial was completed.

Based on this trial design, predict the completion outcome and termination type (if applicable).